Synthesis Capital

What is Synthesis Capital?

Synthesis Capital is a venture capital firm specializing in Food Tech investments, focusing on the transformative potential of food technology and modern biotechnology to redefine the food system. They position themselves as the Future Food Investors, converging smart capital with deep expertise to support visionary founders in overhauling how food is produced and consumed.

The firm's investment strategy revolves around game-changing companies at the intersection of biotechnology and food production, comprising alternative proteins and other innovative food technologies. Synthesis Capital draws on its rich history of involvement in the alternative protein sector, particularly through their team's foundational work with CPT Capital. The team at Synthesis Capital has been instrumental in nurturing the sector's early and most successful enterprises, with investments in a variety of groundbreaking companies in the plant-based, recombinant, cultivated, and single-cell protein industries.

Their portfolio reflects an intensive interest in sustainable food solutions, spanning locations from Los Angeles to Tel Aviv. Their investment criteria are clear, with a minimum investment capacity of $100,000, a maximum of $5,000,000, and a sweet spot investment of around $1,500,000. Synthesis Capital especially targets pre-seed, seed, and Series A funding rounds, reflecting their commitment to early-stage innovation.

Deep involvement doesn't stop with funding; they provide hands-on guidance to startups, leveraging a wealth of investment experience, technical expertise, environmental, social, and governance (ESG) leadership, and industry insights to guide companies from lab conception to boardroom expansion.

The firms' website also emphasizes their sustainable vision and their role as an Appointed Representative of Frank Investments Limited, regulated by the Financial Conduct Authority, underscoring their responsible and ethical investment approach.